Genetics and genome editing

The role of genetics in longevity research is of central importance, as ageing and many age-related diseases can be traced back to genetic and molecular mechanisms. Genes influence how our cells age, how they repair damage and how they react to environmental influences. Certain genes are associated with a longer lifespan or with an increased risk of age-related diseases such as cancer, heart disease and neurodegenerative diseases. In longevity research, scientists are investigating how these genes function and how their activity can be manipulated to prolong life and improve health in old age.

Genome editing, particularly with technologies such as CRISPR/Cas9, has the potential to revolutionize the way we approach the aging process. CRISPR allows researchers to make targeted changes in the genome to correct genetic defects or modify genes that affect ageing. For example, genes that promote cell death or trigger age-related diseases could be deactivated by gene editing or altered to promote healthy cell function. This could be the key to extending lifespan and improving quality of life.

Research in this area focuses on several key mechanisms:

  1. Telomeres: The shortening of telomeres, the end caps of chromosomes, is considered to be one of the main causes of ageing. By manipulating genes responsible for telomerase production, scientists could extend the lifespan of cells by rebuilding telomeres.
  2. DNA repair mechanisms: With increasing age, the ability of cells to repair DNA damage decreases, which can lead to mutations and cancer. Gene editing could be used to improve the efficiency of DNA repair processes.
  3. Epigenetic modification: In addition to the genes themselves, epigenetic markers also play an important role in the ageing process. These markers influence which genes are activated or deactivated in the cells. Targeted epigenetic reprogramming could restore ageing cells to a younger state.


Overall, the combination of genetics and genome editing offers unprecedented opportunities to understand and influence the ageing process. While research is still at a relatively early stage, there have already been initial successes in extending the lifespan of model organisms, highlighting the potential of these approaches for humans.

Swiss radio and television

Schweizer Radio und Fernsehen (SRF) serves the public with a wide range of high-quality programs. The company promotes the free formation of opinion through comprehensive and factual information, conveys cultural values and provides education and entertainment for the public. With its main studios in Zurich, Basel and Berne and regional studios in Aarau, Chur, Lucerne and St. Gallen, SRF strengthens its roots in the broadcasting region. SRF also has a global network of 60 correspondents who gather information on the ground and provide first-hand background information and assessments. SRF is SRG's largest business unit, comprising a total of 17 radio and 7 television channels as well as supplementary websites and teletext services for four language regions. As a non-profit organization, SRG is financed around 75 percent by licence fees and around 25 percent by commercial revenues. It is politically and economically independent.